HCPLive

@HCPLiveNews

Everything you need to enhance your clinical approach to improving patient care.

United States

linktr.ee/HCPLive

Replies Reposts Media

HCPLive
@HCPLiveNews
2h
New at #ESC2026: Ankeet Bhatt, MD, MBA, sat down with the HCPLive editorial team to discuss ADHERE-ASCVD, a trial evaluating digital reminders for statin refill and adherence in patients with ASCVD. Watch now: hcplive.com/view/adhere-as…
00:00
HCPLive
@HCPLiveNews
9h
Molluscum contagiosum mostly affects young children, and until recently, clinicians had no FDA-approved treatment options for it. At LEADderm 2026, Leon Kircik, MD, breaks down why ZELSUVMI (berdazimer) gel, 10.3%, is changing that conversation.
hcplive.com
Why Molluscum No Longer Means 'Watch and Wait,' With Leon Kircik, MD | HCPLive
Leon Kircik, MD, on why an FDA-approved, at-home molluscum option changes practice, and what is exciting for him in dermatology.
HCPLive
@HCPLiveNews
11h
Hematuria often gets mistaken for a UTI, delaying an IgA nephropathy diagnosis by years. Gaia Coppock, MD on what to watch for ⬇️ More:
hcplive.com
Mistaken for a UTI: Diagnosing IgA Nephropathy, With Gaia Coppock, MD | HCPLive
A survey of patients with IgA nephropathy shows how nonspecific symptoms and long referral waits delay diagnosis by up to two years.
HCPLive
@HCPLiveNews
13h
Phase 2b subgroup data showed @SanofiUS's lunsekimig's exacerbation benefit scaled with asthma severity and biomarker levels. Watch Njira Lugogo, MD, University of Michigan, discuss the new data at #ERS2026 now. hcplive.com/view/aircules-…
1
HCPLive
@HCPLiveNews
13h
ICYMI: The @FDA has accepted the #BLA for lonvo-z with priority review for #HAE setting a PDUFA date of March 10, 2027. Read more:
hcplive.com
Lonvo-z BLA Accepted by FDA With Priority Review for HAE | HCPLive
The FDA granted lonvo-z priority review for HAE, setting a PDUFA date of March 10, 2027 based on positive Phase 3 HAELO data.